Tiziana Life Sciences Ltd (NASDAQ:TLSA) said its CEO, Ivor Elrifi, will present at the 9th Annual Neuroscience Innovation Forum on January 11 during J.P. Morgan Healthcare Conference Week in San Francisco.
The company said the presentation will highlight its lead candidate, intranasal foralumab, a fully human anti-CD3 monoclonal antibody. Senior management will also attend meetings with investors and partners.